Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank57
3Y CAGR+123.9%
5Y CAGR+85.4%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+123.9%/yr
vs +57.1%/yr prior
5Y CAGR
+85.4%/yr
Recent acceleration
Acceleration
+66.7pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
21.9x
Strong expansion
Streak
5 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $19.62M | +5.2% |
| 2024 | $18.65M | +162.3% |
| 2023 | $7.11M | +306.5% |
| 2022 | $1.75M | +61.5% |
| 2021 | $1.08M | +21.0% |
| 2020 | $895000.00 | -1.2% |
| 2019 | $906000.00 | +215.7% |
| 2018 | $287000.00 | -99.4% |
| 2017 | $46.27M | -27.1% |
| 2016 | $63.45M | - |